Motion stimulation therapy market is projected to reach USD 1.4 billion by 2024. A CAGR of 3.8% is estimated between 2024 and 2034. Towards the end of 2034, the market is predicted to reach USD 2 billion.
Through immersive virtual environments, distraction treatment is used to relieve pain by distracting patients from aches and pains. The implementation of customized digital duties can also contribute to relaxation techniques such as deep breathing.
The use of VR simulations allows patients to practice functional movements such as walking in a safe environment. In conditions such as Parkinson's disease and stroke, stability training and gait analysis/correction are most beneficial. Therapy in VR can promote neuroplasticity and motor learning by immersing patients in repetitive movements.
Combined with rich sensory feedback, the education optimizes the rehabilitation process and keeps patients engaged during the rehabilitation process. By increasing blood flow, waste is removed and vitamins are transported more effectively, therefore fatigue is reduced at some point during the exercise. Stroke survivors with spasticity or muscle spasms may benefit from stim remedies to loosen and improve their mobility following painful spasms and tightness.
Motion Stimulation Therapy Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 1.3 billion |
| Estimated Size, 2024 | USD 1.4 billion |
| Projected Size, 2034 | USD 2 billion |
| Value-based CAGR (2024 to 2034) | 3.8% |
An intellectual disorder may be treated by brain stimulation healing techniques, which involve activating or inhibiting the brain. Electrodes implanted within the mind or positioned directly on the scalp can administer these remedies simultaneously. The use of neuroplasticity is critical to the treatment of intellectual disorders and the restoration of voluntary movement after strokes and spinal cord injuries.
An electrical stimulus to the muscles around a joint known as neuromuscular electrical stimulation (NMES) enhances and maintains the variety of motion around the joint. At some point of stimulation, it stimulates electrically controlled muscle contractions to maximize normalized torque. As far as motor unit recruitment order and smoothness of contraction onset, this approach differs from physiological muscle contractions.
The selection of the most appropriate stimulation parameters is crucial to maximizing the therapeutic benefits of DBS. By sensing local field potentials (LFPs) transmitted by the DBS leads, recent advances allow DBS to be programmed based on neural activity. A more personalized programming approach is thus possible that adapts to changes in the patient's condition over time.
Clinicians and patients can save time by automating programming with wearable sensors and laptop-managed updates. Programming remotely also facilitates more accessible MST therapy since modifications can be made instantly without an in-person visit to the professional.
Sensors, such as smartwatches and fitness trackers, can help therapists tailor physical activities more precisely by measuring posture, gait, muscle activity, and different goals. The use of augmented reality (AR) gadgets in rehabilitation, both inside and outside of health facilities, could enhance motor abilities and engagement.
An actuator-equipped wearable that can provide tremor relief and gait support for people suffering from Parkinson's disease is being developed. This technology would include a vibrotactile glove that stimulates the fingertips to relieve symptoms. Wearable sensors that provide real-time kinematic information to improve the treatment of motor complaints and adapt deep brain stimulation therapies.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The following table shows the anticipated CAGR for motion stimulation therapy based on several semi-annual periods from 2024 to 2034. A growth rate of 4.8% is forecast for the first half of the year (H1), followed by a 4.5% growth rate for the second half (H2).
| Particular | Value CAGR |
|---|---|
| H1 | 4.8% (2023 to 2033) |
| H2 | 4.5% (2023 to 2033) |
| H1 | 3.8% (2024 to 2034) |
| H2 | 3.4% (2024 to 2034) |
According to estimates, the first half of 2024 CAGR will be 3.8%, and the second half will be slightly lower at 3.4%.
Development of New Designs and Awareness will Influence the Motion Stimulation Therapy Market
The growing incidence of Parkinson's disease is driving the growth of the motion stimulation market. As the number of accidents and muscle injuries increases, so will the market for movement stimulation remedies. The motion stimulation remedy can also be used in conjunction with modern medicine. Both patients and healthcare providers benefit from MST's effectiveness and accessibility.
Its growing adoption is also attributed to an increased awareness and understanding of the benefits of MST among medical specialists and the general public. Identifying the long-term price benefits of effective rehabilitation also plays an important role in promoting MST adoption by healthcare guidelines and insurance vendors.
Clinical trials and investment in research and development will be emphasized to drive the industry's growth. Electrical stimulation devices have made improvements in design, electrode technology, and programming capability.
This has resulted in more user-friendly, safer, and accurate motion stimulation therapy devices. Increasing recognition and acceptance of motion stimulation therapies' including their ability to reduce muscle spasms, provide pain relief, and prevent muscle atrophy, are driving the market's growth.
Personalized Treatment Integrated with AI and ML to Create New Opportunities
Through the integration of emerging technologies such as artificial intelligence and machine learning, patients' outcomes can be improved by personalized and optimized treatment protocols. Improvements in wearable technologies and telehealth services will facilitate the expansion into home-based treatment solutions. Patients who suffer from mobility problems or live in remote areas could benefit from the MST program.
Collaborations among healthcare vendors and tech organizations can foster modern products and services, improving the MST landscape. There is an enormous ability for MST in sports medicine and injury prevention, wherein it could be used to optimize performance and healing.
Finally, expanding MST into underserved industries and regions with limited access to traditional bodily therapies can assist in minimizing healthcare gaps and improve overall community health.
The FDA has approved trigeminal nerve stimulation for the treatment of attention-deficit/hyperactivity disease (ADHD) among children, but it is not yet approved for other conditions or for adults. Transcranial random noise stimulation, transcranial interference, transcranial alternating contemporary stimulation, and transcranial ultrasound stimulation are other noninvasive brain stimulation therapies in development.
This new brain stimulation treatment option is actively being studied by researchers at the National Institute of Mental Health, which is working to expand safer, more powerful, and personalized interventions for extreme intellectual disabilities.
Advancement in Technologies to Fuel Motion Stimulation Therapy Market
Customized therapy is becoming increasingly popular, driven by data analytics and patient-specific customization. The use of augmented reality (AR) and virtual reality (VR) in MST is on the rise, enhancing engagement and effectiveness with immersive environments. With the advancement and expansion of robot technology, assistive gadgets, and robot exoskeletons are also becoming more popular.
MST is increasingly incorporating wearable and IoT devices to enable continuous tracking and real-time feedback, which contribute to the success of treatment. The COVID-19 pandemic has increased the focus on telehealth and distant tracking, allowing MST to adjust to a variety of settings. The use of MST protocols is continuously being refined and demonstrated to work, with a strong trend toward evidence-based practices.
High Cost of Devices and Treatments Limit Motion Stimulation Therapy Use
In low-income areas, MST devices and generation can be extremely expensive, limiting accessibility and adoption. Healthcare vendors may also need specialized education to effectively utilize and implement MST technologies. The development and deployment of new MST innovations can also be inhibited by regulatory hurdles and a need for rigorous scientific validation.
Integration of MST into conventional healthcare is also challenging, as it must complement traditional therapy methods rather than compete with them. Patients may have difficulty adhering to and motivating home-based therapy programs, especially with limited supervision. For a telehealth platform or connected device to be trusted and compliant, data security and patient privacy are critical concerns.
Principal Consultant
A CAGR of 6.8% was recorded by the motion stimulation therapy market between 2019 and 2023. It is estimated that motion stimulation therapy is expected to generate USD 1.3 billion by 2023, compared to USD 234.5 billion in 2019.
A variety of advanced treatments are being developed, including purposeful stimulation and healing electric stimulation. By using these methods, better results will be achieved and the recovery process will be sped up. Deep brain stimulation has been expanded to treat Parkinson's disease, which is a type of motion stimulation. In the treatment of Parkinson's disease, deep brain stimulation is the most commonly used surgical procedure.
Software advancements such as closed-loop stimulation and far-away programming, in addition to hardware upgrades, can enhance stimulation. This may lead to more tailored and accessible movement stimulation therapies. Studies focused on using motion stimulation therapy for a broader range of conditions beyond just musculoskeletal conditions, such as Parkinson's disease, are ongoing.
Such therapy is increasingly incorporating virtual reality (VR) to improve rehabilitation outcomes and patient engagement. Through virtual reality, patients can experience customized rehabilitation environments tailored to their individual needs. A secure, managed environment can be used to simulate real-world activities, including movements with purpose.
To increase engagement and motivation amongst sufferers, VR-based treatment frequently incorporates gamification elements. Providing real-time biofeedback to patients can also assist them in monitoring their development.
The therapists can guide sufferers through VR stories, stimulating neural pathways and selling neuroplasticity and motor learning through repetitive movements. To optimize the rehabilitation method, sensory feedback, and project-specific education are provided.
Tier 1 companies dominate the global market, accounting for 59.6% of its revenue in 2023. Players focus on continuous innovation, extensive distribution networks, and offering a comprehensive product line. A company's position in the marketplace is largely determined by its scale, its financial stability, and its brand reputation.
The company maintains its competitive edge in neuromodulation through research and development, partnerships, and a broad distribution network. Prominent companies within Tier 1 include Medtronic, Boston Scientific Corporation, and St. Jude Medical Inc. (Abbott Laboratories).
With 25.9% of the share in 2023, Tier 2 players hold the majority of the market. Players are emphasizing innovations in technology and clinical outcomes to reduce paresthesia, a common side effect of traditional spinal cord stimulation.
To capture industry, share, the company relies on scientific evidence and specialist knowledge to target specific neurological conditions with VNS therapies. With its focused approach, the companies can specialize deeply and build strong brand loyalty. Tier 2 companies include Nevro Corporation, and Cyberonics (LivaNova PLC).
By addressing specific patient needs in rehabilitative care and mobility, Tier 3 companies compete with Tier 1 and Tier 2. Through targeted neurostimulation solutions, companies aim to improve the quality of life of patients. Companies can create long-term customers and increase their revenue by providing excellent customer support, patient education, and tailored solutions. Prominent players Bioness Inc., and Innovative Neurotronics Inc.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Various countries are analyzed below for motion stimulation therapy. This study examines several regions across the globe, including Asia Pacific, Europe, and North America. With a 4.6% CAGR through 2034, India will remain the leader in Asia Pacific. It is predicted that the United Kingdom will exhibit a 1.4% CAGR by 2034.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| United States | 1.1% |
| Canada | 1.9% |
| United Kingdom | 1.4% |
| Germany | 1.2% |
| India | 4.6% |
| China | 4.4% |
| South Korea | 3.5% |
Increasing sedentary lifestyles and health problems are driving motion stimulation therapy. Increasing numbers of athletes and fitness enthusiasts are using them to enhance their performance and recovery.
Specifically, in the areas of physical rehabilitation, sports therapy, and pain control, motion stimulation therapy (MST) is gaining popularity in the United States. Improvements in motion stimulation devices and the supply of extra reachable home therapy solutions are riding more adoption of these remedies inside the United States.
As the population ages, continuous diseases like arthritis are increasing, causing a demand for innovative healing interventions. Health insurance coverage and superior clinical technology make MST a feasible option in the United States. Patients and healthcare vendors alike also emphasize noninvasive treatment alternatives, driving the market.
Motion stimulation therapy is expanding due to the growing number of Parkinson's patients in the United States, estimated at nearly 60,000 new situations each year. A healing procedure such as this can help control the effects of Parkinson's disease.
Adoption of the latest remedies and increasing interest in nonpharmacological treatment options for pain control and mobility improvement. Physiotherapy and rehabilitation programs in the United Kingdom are increasingly incorporating MST as part of holistic care.
Sports activity accidents and the demand for green restoration solutions among athletes and active individuals in the United Kingdom are factors contributing to a rise in MST demand.
A rise in reimbursements and insurance coverage is also expected to boost the industry for MST. The trend of chronic diseases and the growing demand for home healthcare will also increase demand for MST in the region. According to the forecast, the industry will increase at a CAGR of 1.4% during the forecast period.
A growing population, combined with an increased focus on physical therapy and rehabilitation, has led to a rapid growth of motion stimulation therapy (MST). A sizeable need for powerful therapeutic interventions is emerging as lifestyle-related diseases such as obesity, diabetes, and arthritis rise.
With the introduction of superior technologies like MST, India's healthcare infrastructure is evolving. Even though rural areas are also seeing a rise in adoption, the focus is shifting more towards urban centers. An annual growth rate of 4.6% is expected to be achieved by India between 2024 and 2034.
As an alternative to lengthy-term medications or surgery, MST offers patients an affordable and non-invasive alternative for pain management and rehabilitation.
A growing number of athletes and fitness enthusiasts in India, who seek efficient healing and performance enhancement solutions, also contribute to the demand for MST. Along with public-private partnerships, government projects are helping MST take off, aiming to improve healthcare quality and accessibility.
A description of the leading segments in the industry is provided in this section. Functional Neuromuscular therapy accounted for 37.15% of the total market in 2023. Based on the end user, hospitals accounted for 45.7% of the market in 2023.
| Therapy | Functional Neuromuscular Therapy |
|---|---|
| Value Share (2023) | 37.15% |
NMES therapy aims to artificially trigger movement in paralyzed individuals by using low-power electrical pulses. NMES therapy assists in increasing power and range of motion, retraining and reteaching muscle tissues to function, and rebuilding energy following surgery or disuse.
This drug can also be used for the prevention or treatment of muscle atrophy if it is administered to people with intact nerves. Sports medicine applications of NMES include strengthening the muscles, maintaining muscle mass, retraining the muscles, and manipulating edema
The NMES treatment is provided in a variety of medical settings, such as outpatient occupational therapy and physical therapy. As a treatment alternative, it assists patients in regaining power or range in specific muscle groups and is accessible through a wide range of technologies.
In studies, NMES is effective when used along with standard dysphagia treatment. The use of NMES for lengthy-term dysphagia is found to be beneficial in some studies but does not add any gains to normal treatment in some studies.
| End User | Hospitals |
|---|---|
| Value Share (2023) | 45.7% |
A hospital is at the forefront of motion stimulation therapy in terms of implementing multidimensional initiatives, assessing effectiveness, providing specialized care, and participating in market growth. The purpose of these efforts is to reduce the load of sedentary behavior on patients during hospitalization and improve patient outcomes.
During hospitalization, patients' motion behavior is improved through motion stimulation therapy in a variety of ways. An analysis is created to aesthetically enhance motion conduct through the collaboration of multidisciplinary groups.
Using ward-specific motion plans and interventions, multidisciplinary teams in an academic sanatorium in the Netherlands conducted a 10-month project to enhance motion conduct in wards.
Multidisciplinary teams worked together on the Hospital in Motion mission and implemented specific motion plans to enhance mobility. Patients who use this method spend less time sleeping during their stay in the hospital, indicating a good impact on their mobility.
The use of virtual reality, multisensory stimulation, and immersive play in hospitals contributes to motion stimulation therapy as well. Interacting with motion-activated interactive programs helps patients distract from pain, stay motivated, and engage, enhancing their physical and cognitive abilities.
Key companies compete based on the integration of technology, patient-centered care, and strategic partnership initiatives. A combination of motion tracking, VR, augmented reality (AR), and artificial intelligence (AI) can make therapy more engaging for patients and assist in improving accuracy.
As part of the clinical validation effort, the organization invests in research and development, collaborates with academic institutions, and publishes findings to establish credibility.
Recent Industry Developments
In terms of therapy type, the industry is segregated into functional neuromuscular motion stimulation therapy, peripheral motion stimulation therapy, deep brain motion stimulation therapy, and therapeutic electrical motion stimulation therapy.
In terms of end users, the industry is segmented into hospitals, specialty clinics, and others.
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia, East Asia, the Middle East, and Africa have been covered in the report.
Motion stimulation therapy is projected to expand at a CAGR of 3.8% between 2024 and 2034.
The functional neuromuscular motion stimulation therapy segment held a market share of 37.15% in 2023.
The market for motion stimulation therapy is projected to reach USD 2 billion by 2034.
During the assessment period, the United States is projected to experience a CAGR of 1.1%.
The key players in the motion stimulation therapy industry include Valencia CA USA, Cyberonics, Medtronic, and Innovative Neurotronics Inc.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy Type 6.1. Functional Neuromuscular Motion Stimulation Therapy 6.2. Peripheral Motion Stimulation Therapy 6.3. Deep Brain Motion Stimulation Therapy 6.4. Therapeutic Electrical Motion Stimulation Therapy 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 7.1. Hospitals 7.2. Specialty Clinics 7.3. Other End Users 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. South Asia and Pacific 8.5. East Asia 8.6. Middle East and Africa 9. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 10. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 11. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. South Asia and Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. Middle East and Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. Sales Forecast 2024 to 2034 by Therapy Type and End User for 30 Countries 16. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 17. Company Profile 17.1. Valencia CA USA 17.2. Cyberonics 17.3. Medtronic 17.4. Innovative Neurotronics Inc. 17.5. Boston Scientific Corporation 17.6. Bioness Inc. 17.7. St. Jude Medical Inc. 17.8. Nevro Corporation
Explore Healthcare Insights
View Reports
Motion Stimulation Therapy Market
